S'abonner

Poor cardiorespiratory fitness may be an indicator of more severe liver inflammation in non-alcoholic fatty liver disease patients - 11/08/23

Doi : 10.1016/j.clinre.2023.102163 
Luciana Carneiro Pena a, Cláudia Alves Couto a, b, c, Bernardo Henrique Mendes Correa d, Luisa Fabiana Queiroz Ferrua d, Guilherme Grossi Lopes Cançado c, e, Luciana Costa Faria a, b, c, Eliane Viana Mancuzo b, f, Teresa Cristina Abreu Ferrari a, b, c,
a Programa de Pós-Graduação em Ciências Aplicadas à Saúde do Aduto, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil 
b Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil 
c Instituto Alfa de Gastroenterologia, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil 
d Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil 
e Hospital da Polícia Militar de Minas Gerais, Belo Horizonte, MG, Brazil 
f Serviço de Pneumologia e Cirurgia Torácica, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil 

Corresponding author at: Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Av. Professor Alfredo Balena 190, Belo Horizonte, MG 30130-100, Brazil.Departamento de Clínica Médica, Faculdade de MedicinaUniversidade Federal de Minas GeraisAv. Professor Alfredo Balena 190Belo HorizonteMG30130-100Brazil

Highlights

Liver inflammation may be a mechanism of very poor/poor fitness in non-alcoholic fatty liver disease patients.
According to this study, non-alcoholic steatohepatitis and sedentarism were independently associated with very poor/poor cardiorespiratory fitness.
This study provides evidence that there is no correlation between VO2max determined by the ergometric test and the six-minute walk test.

Le texte complet de cet article est disponible en PDF.

Abstract

Introduction

Non-alcoholic fatty liver disease (NAFLD) is related to cardiovascular disease. Cardiorespiratory fitness (CRF) is an important indicator of cardiovascular health. Therefore, we aimed to evaluate the CRF of NAFLD patients.

Methods

Cross-sectional study, including 32 patients with biopsy-proved NAFLD. The patients underwent ergometric test (ET) and six-minute walk test (6MWT) to determine CRF. The test results were compared to disease parameters and with each other.

Results

Considering the ET, 20 (62.5%) patients had very poor or poor CRF, and in 12 (37.5%), it was regular or good. In the 6MWT, 13 (40.6%) individuals had poor CRF, in 12 (37.5%), it was very poor, and in seven (21.9%), regular. NAFLD activity score (NAS) ≥5 was observed in 12 (37.5%) individuals. Twelve (37.5%) patients were sedentary, 11 (34.4%), insufficiently active, and nine (28.1%), active. Obesity and liver inflammation on biopsy were associated with very poor/poor CRF. NAS ≥5 and sedentary lifestyle were independently associated with very poor/poor CRF by ET. Although mean VO2max values determined by both tests were similar, no correlation of VO2max determined by ET and 6MWT was observed, as occurred for the distance walked in 6MWT and values of metabolic equivalent (MET) determined by ET. There was no reproducibility between CRF determined by ET and 6MWT.

Conclusion

Most NAFLD patients had very poor or poor CRF. Severe liver injury (NAS ≥5) and sedentary lifestyle were independently associated with very poor/poor fitness, according to ET. No reproducibility was observed between the CRF defined by ET and 6MWT.

Le texte complet de cet article est disponible en PDF.

Keywords : Non-alcoholic fatty liver disease, Ergometric test, 6-minute walk test, Physical fitness, Cardiorespiratory fitness

Abbreviations : NAFLD, CRF, ET, 6MWT, NASH, VO2max, TG, HDL, AC, BMI, SPO2, IPAQ, MET, MS, SD, IQR


Plan


© 2023  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 47 - N° 7

Article 102163- août 2023 Retour au numéro
Article précédent Article précédent
  • Safety and efficacy of postoperative adjuvant therapy with atezolizumab and bevacizumab after radical resection of hepatocellular carcinoma
  • Zhi-Xi Li, Qi-Fan Zhang, Jia-Ming Huang, Shao-Jian Huang, Han-Biao Liang, Hao Chen, Zhan-Hong Lai, Qing-Yan Li, Jian-Ping Qian, Kai Wang, Jie Zhou
| Article suivant Article suivant
  • Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
  • Sanjay Bandyopadhyay, Shambo Samrat Samajdar, Saibal Das

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.